EMBL Australia

An international study co-led by EMBL Australia group leader Dr Yann Gambin has revealed a potential mechanism the SARS-CoV-2 virus may use to try to temper the host’s innate immune defence.

A clinical human trial of malaria infection led by EMBL Australia group leader Dr Michelle Boyle has linked the activation of specific immune cells to the induction of protective antibodies against malaria - an important step towards the development of an effective vaccine.

Three EMBL Australia group leaders have been awarded NHMRC Ideas Grants to expand their research in malaria, cancer cell biology and antibiotic resistance.

EMBL Australia Scientific Head Professor James Whisstock is leading the development of an integrated microscopy and proteomics resource that will enable Australian researchers to understand the precise molecular makeup of the intracellular environment.

EMBL Australia group leader Dr Maté Biro has contributed to an unexpected discovery about cancer cells.

Dr Vaishnavi Ananthanarayanan, based at UNSW Sydney’s Single Molecule Science, is interested in the dynamic inner workings of a cell.

EMBL Australia group leader Associate Professor Chen Davidovich has been awarded a prestigious Viertel Senior Medical Research Fellowship of $1.25 million to investigate how genes operate.

EMBL Australia group leaders Professor Eduardo Eyras and Associate Professor Max Cryle have been awarded Discovery Project grants in the areas of genetics and antimicrobial resistance, respectively.

Immune T cells swarm to tumours by following a chemical gradient left by other cancer-killing T cells, a pre-clinical study by EMBL Australia group leader Dr Maté Biro and his team has shown.

EMBL Australia group leader Dr Harald Janovjak was recently awarded a prestigious ARC Future Fellowship to develop innovative genomic tools.